Clinical Trial Update: Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD) [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluated Cx601 (darvadstrocel), an allogeneic adipose-derived stem cell therapy, for complex perianal fistulas in Crohn's disease. Results h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Cx601 (darvadstrocel)

Snippet

Sponsor: Tigenix S.A.U. | Conditions: Crohn's Disease | Phase 3 | Status: COMPLETED | Results posted: 2024-09-19